OSTX
OS Therapies Incorporated
1.70$
+0.6%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | +0.0% | – | – | -50.0% | +16,089.1% | +11.0% | +0.0% | +0.0% | +0.0% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +125.8% | -64.5% | +9.6% | +205.2% | -28.2% | +50.6% | +90.9% | +50.2% | +435,368.1% | -100.0% | +83,954.5% | – | |
| – | -20.8% | +102.0% | +42.8% | +220.2% | +70.8% | +76.1% | -36.6% | +33.6% | +394,957.9% | -100.0% | +88,713.4% | – | |
| – | +87.0% | -45.5% | +23.7% | +212.6% | +21.6% | +68.6% | -5.5% | +45.6% | +72.4% | -15.3% | -15.9% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -77.3% | +169.5% | -6.2% | -43.7% | -98.3% | -100.0% | – | – | – | – | -92.6% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.